Literature DB >> 8380086

Membrane association of functional vesicular stomatitis virus matrix protein in vivo.

L D Chong1, J K Rose.   

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) is a major structural component of the virion which is generally believed to bridge between the membrane envelope and the ribonucleocapsid (RNP) core. To investigate the interaction of M protein with cellular membranes in the absence of other VSV proteins, we examined its distribution by subcellular fractionation after expression in HeLa cells. Approximately 90% of M protein, expressed without other viral proteins, was soluble, whereas the remaining 10% was tightly associated with membranes. A similar distribution in VSV-infected cells has been observed previously. Conditions known to release peripherally associated membrane proteins did not detach M protein from isolated membranes. Membrane-associated M protein was soluble in the detergent Triton X-114, whereas soluble M protein was not, suggesting a chemical or conformational difference between the two forms. Membranes containing associated M protein were able to bind RNP cores, whereas membranes lacking M protein were not. We suggest that this membrane-bound M fraction constitutes a functional subset of M protein molecules required for the attachment of RNP cores to membranes during normal virus budding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380086      PMCID: PMC237377     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes.

Authors:  P H Atkinson; S A Moyer; D F Summers
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

2.  Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus.

Authors:  D M Knipe; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

3.  The relationship between autointerference and the replication of defective interfering particle.

Authors:  S R Khan; R A Lazzarini
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

4.  Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein.

Authors:  D S Lyles; M McKenzie; J W Parce
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Assembly of the vesicular stomatitis virus envelope: incorporation of viral polypeptides into the host plasma membrane.

Authors:  A E David
Journal:  J Mol Biol       Date:  1973-05-05       Impact factor: 5.469

7.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant.

Authors:  M A Whitt; L Chong; J K Rose
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  The M protein of vesicular stomatitis virus associates specifically with the basolateral membranes of polarized epithelial cells independently of the G protein.

Authors:  J E Bergmann; P J Fusco
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

View more
  61 in total

1.  Membrane association induces a conformational change in the Ebola virus matrix protein.

Authors:  S Scianimanico; G Schoehn; J Timmins; R H Ruigrok; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.

Authors:  R E Kiernan; A Ono; E O Freed
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment.

Authors:  Larissa Kolesnikova; Harald Bugany; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

Authors:  S S Chen; S F Lee; C T Wang
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Intracellular hepadnavirus nucleocapsids are selected for secretion by envelope protein-independent membrane binding.

Authors:  H Mabit; H Schaller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Characterization of the Interaction between the Matrix Protein of Vesicular Stomatitis Virus and the Immunoproteasome Subunit LMP2.

Authors:  Frauke Beilstein; Linda Obiang; Hélène Raux; Yves Gaudin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

9.  Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein.

Authors:  Shinji Watanabe; Masaki Imai; Yoshiro Ohara; Takato Odagiri
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction.

Authors:  R N Harty; M E Brown; J P McGettigan; G Wang; H R Jayakar; J M Huibregtse; M A Whitt; M J Schnell
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.